small business Grant Search

The following government grants in the FederalGrants.com database contain the term small business in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Autism Centers of Excellence: Networks (R01 Clinical Trial Optional) 93.113, 93.173, 93.242, 93.853, 93.865 RFA-HD-22-007
OSBDC Funding Opportunity 59.037 OSBDC-2022-05
Limited Competition: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed) 93.310 RFA-RM-21-014
Autism Centers of Excellence: Centers (P50 Clinical Trial Optional) 93.113, 93.173, 93.242, 93.853, 93.865 RFA-HD-22-008
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) 93.853 PAR-21-282
Science and Technology Projects Related to Coal Mining and Reclamation; Applied Science Projects 15.255 S21AS00363
HIV Prevention and Alcohol (R34 Clinical Trials Optional) 93.273 RFA-AA-21-017
HIV Prevention and Alcohol (R01 Clinical Trials Optional) 93.273 RFA-AA-21-016
Strengthening Syringe Services Programs 93.488 CDC-RFA-PS22-2208
Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional) 93.242, 93.853 RFA-MH-21-250
Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 PAR-21-314
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 PAR-21-315
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) 93.172, 93.847 PAR-21-313
Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed) 93.242, 93.853 RFA-MH-21-251
Research Experiences for Teachers (RET) in Engineering and Computer Science 47.041, 47.070 21-606
Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-026
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879 PAR-21-271
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) 93.242 PAR-21-316
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.866, 93.867 PAR-21-272
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) 93.242, 93.307 RFA-MD-22-001
Pandemic Response and Safety Grant Program 10.181 USDA-AMS-TM-PRS-G-21-0011
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH)) 93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.853, 93.866, 93.867 PAR-21-273
Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) 93.113 RFA-ES-21-008
Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed) 93.121, 93.313 RFA-DE-22-005
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed) 93.847 RFA-DK-21-017
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) 93.242, 93.273, 93.279, 93.313, 93.855, 93.865 RFA-AI-21-058
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) 93.113 RFA-ES-21-009
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) 93.866 PAR-21-308
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) 93.393, 93.399, 93.847, 93.865 PAR-21-305
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) 93.866 PAR-21-307
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) 93.279 RFA-DA-22-022
Creating an Educational Nexus for Training in Experimental Rigor (CENTER) (UC2 Clinical Trial Not Allowed) 93.853 RFA-NS-21-009
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-024
Resource Center for Tribal Epidemiological Centers (RC-TEC) (U24 Clinical Trial Not Allowed) 93.307 RFA-MD-21-003
Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth 93.136 RFA-CE-22-002
Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18) 93.226 RFA-HS-22-001
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1)(Clinical trials not allowed) 93.172 RFA-HG-21-029
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed) 93.172 RFA-HG-21-030
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U24 Clinical trials not allowed) 93.172 RFA-HG-21-031
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-023
Search Results 3121-3160 of 21068
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com